• 20 mg cromolyn acid, disodium salt

• water, purified
• sodium chloride

Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer indication

• This medicine is used to prevent asthma symptoms in mild persistent (persistent) allergic and nonallergic asthma (stage 2 of the asthma staging scheme).
• A notice:
  • This medicine is not suitable for the treatment of acute asthma attacks.

dosage Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer

• Always use the inhalation solution exactly as instructed. Please ask your doctor or pharmacist if you are not sure.
• Unless otherwise prescribed by the doctor, is the usual dose
  • In the beginning, it makes sense to use it 4 times a day.
  • The indicated daily doses can be doubled, the frequency of application increased to 6 times a day.
  • After the therapeutic effect has been reached, the dosing intervals can be gradually increased to the extent necessary to maintain freedom from symptoms.
  • In asthma therapy, sodium cromoglicate is only suitable for preventing asthmatic symptoms, but not for treating acute asthma attacks. A trial dose should be given for at least 4 weeks. The full effect generally sets in after 2 - 4 weeks. A gradual dose reduction over 1 week is recommended.
• Adults and children 1 ampoule each 4 times a day (2 ml solution contain 20 mg active substance). Can be used from the age of 2.

• How long should you use Pädiacrom inhalation solution?
  • Sodium cromoglicate is used to prevent asthmatic symptoms as long-term therapy. The inhalation solution can only work properly if it is used regularly according to the doctor's instructions.
  • The duration of the usage will be decided by the medicating doctor.
  • Please talk to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.

• If you use more than you should:
  • Symptoms of poisoning are not yet known for sodium cromoglicate. Treatment is not necessary.

• If you forgot the application:
  • Do not take a double dose to make up for a forgotten dose. Please keep in mind that only regular use leads to the desired effect.

• Effects when treatment is stopped:
  • If you stop treatment, your symptoms may get worse or come back.

way Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer

• The solution for inhalation is intended for local - inhalation use only.
• Children should only inhale the medicine under adult supervision.
• Special inhalation devices (nebulizers) are used for inhalation. The solution must not be used for injection or ingestion.
• In order to achieve an optimal therapy effect, detailed instruction of the patient in the use of these special devices is required. In the case of children, it is particularly important to ensure that the inhalation device is suitable for the corresponding age.

side effects

• The evaluation of side effects is based on the following frequency information:
  • Very common: more than 1 in 10 people treated
  • Common: more than 1 in 100 people treated
  • Uncommon: more than 1 in 1000 people treated
  • Rare: more than 1 in 10,000 people treated
  • Very rare: affects 1 or less in 10,000 people including isolated cases
• Respiratory tract:
  • Throat irritation, hoarseness, cough
  • Very rare: paradoxical spasms of the bronchial muscles (bronchospasm), eosinophilic pneumonia (pneumonia)
• Generalized disorders/ immune system:
  • Hypersensitivity reactions: skin rash, itching, hives (urticaria), swelling of the skin and mucous membranes (angioedema)
  • Very rare: severe allergic (anaphylactic) reactions with spasms of the bronchial muscles (bronchospasm) and swelling of the larynx mucosa (larynx oedema)
• Gastrointestinal tract:
  • Nausea, unpleasant taste
• Musculoskeletal System:
  • muscle and joint pain
• If you notice any side effects that are not listed, please tell your doctor or pharmacist.
• If side effects occur, please contact your doctor.
• If eosinophilic pneumonic infiltrates occur during sodium cromoglicate therapy, this must be discontinued immediately.
• Tell your doctor or pharmacist if you notice any side effects not listed.

interactions Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer

• Interactions with other agents
  • Not known.

Contraindications

• This medicine must not be used
  • if you are allergic (hypersensitive) to sodium cromoglicate.

pregnancy Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer and breast feeding period

• Pregnancy:
  • There are no indications of a teratogenic effect of this drug either from animal studies or from previous experience with humans. Nevertheless, for fundamental reasons, you should only use the inhalation solution during pregnancy if the doctor deems it necessary.
• Breastfeeding:
  • Small amounts of the active ingredient in the inhalation solution pass into breast milk. Therefore, you should only use the drug during breastfeeding if the doctor deems it necessary.

patient Asthma symptoms, Asthmatic symptoms, DNCG ISO solution for a nebulizer notes

• Particular caution is required when using Pediacrom inhalation solution:
  • Children:
    • In children, regular monitoring of the course of the disease is particularly important to ensure that the medicine is sufficiently effective.
    • Otherwise, therapy with glucocorticoids should be switched to.
  • Other notes:
    • Asthma therapy should be carried out in stages according to the degree of severity. The success of the treatment should be checked by regular medical examinations and by daily self-monitoring (e.g. by recording the breath measured with the peak flow meter).
    • In the acute asthma attack, a short-acting inhaled beta-mimetic should be used.
    • Suddenly stopping the inhalation solution can worsen the underlying condition. Gradual withdrawal is recommended.

• Driving and using machines:
  • There are no special precautions required.